Clinical trial · people

Ac-SDKP: blood levels fell after kidney transplant in 14 patients

Checked against the paper Clinical trialPublished by PepVault

The takeaway

This paper is about the body's own Ac-SDKP, not a dose someone takes: it suggests blood levels of the peptide depend largely on how well the kidneys work.

Kind
Clinical trial
Studied in
People
Number studied
14
Published
2014
Journal
Biol Pharm Bull

What they tested

The team tested whether better kidney function after a kidney transplant changes how much Ac-SDKP the body carries in its blood.

How the study was done

A small clinical study in 14 patients with end stage renal disease (kidney failure) having their first kidney transplant, each compared with their own levels before surgery and with no separate comparison group. Blood levels of Ac-SDKP were measured before surgery and at 3, 7, 10, 14, 21, 30, 60 and 90 days after.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Ac-SDKP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Plasma Ac-SDKP was significantly lower from day 3 after the transplant than before it. Creatinine clearance, a measure of how well the kidneys filter blood, rose significantly from day 7. Across the whole period from before surgery to day 90, higher creatinine clearance went with lower Ac-SDKP. In a stepwise multiple regression, creatinine clearance was the only independent factor significantly linked to Ac-SDKP levels.

What it doesn’t show

This was a small study of 14 people with no separate comparison group, followed for 90 days. It measured the body's own Ac-SDKP, detected as an Ac-SDKP-like substance, rather than giving the peptide as a treatment, and it shows a link with kidney function rather than proving cause.

The paper

Suzuki et al. Significant decrease in plasma N-acetyl-seryl-aspartyl-lysyl-proline level in patients with end stage renal disease after kidney transplantation. Biol Pharm Bull. 2014.

The compound

More studies on Ac-SDKP

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Ac-SDKP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo